These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1703498)

  • 1. Development of D1 and D2 dopamine receptors and associated second messenger systems in fetal striatal transplants.
    Helm GA; Robertson MW; Jallo GI; Simmons N; Bennett JP
    Exp Neurol; 1991 Feb; 111(2):181-9. PubMed ID: 1703498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
    Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional changes of striatal dopamine receptors following denervation by 6-hydroxydopamine and fetal mesencephalic grafts in the rat.
    Gagnon C; Bédard PJ; Rioux L; Gaudin D; Martinoli MG; Pelletier G; Di Paolo T
    Brain Res; 1991 Sep; 558(2):251-63. PubMed ID: 1838295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of dopamine receptors and associated mRNA in transplants of human fetal striatal tissue in rodents with experimental Huntington's disease.
    Pundt LL; Narang N; Kondoh T; Low WC
    Neurosci Res; 1997 Apr; 27(4):305-15. PubMed ID: 9152043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal striatal tissue grafts into excitotoxin-lesioned striatum: pharmacological and behavioral aspects.
    Norman AB; Giordano M; Sanberg PR
    Pharmacol Biochem Behav; 1989 Sep; 34(1):139-47. PubMed ID: 2626445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal striatal transplants restore electrophysiological sensitivity to dopamine in the lesioned striatum of rats with experimental Huntington's disease.
    Chen GJ; Jeng CH; Lin SZ; Tsai SH; Wang Y; Chiang YH
    J Biomed Sci; 2002; 9(4):303-10. PubMed ID: 12145527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postnatal development of striatal dopamine function. I. An examination of D1 and D2 receptors, adenylate cyclase regulation and presynaptic dopamine markers.
    Broaddus WC; Bennett JP
    Brain Res Dev Brain Res; 1990 Mar; 52(1-2):265-71. PubMed ID: 2331795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postnatal development of striatal dopamine function. II. Effects of neonatal 6-hydroxydopamine treatments on D1 and D2 receptors, adenylate cyclase activity and presynaptic dopamine function.
    Broaddus WC; Bennett JP
    Brain Res Dev Brain Res; 1990 Mar; 52(1-2):273-7. PubMed ID: 2110042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoradiographic identification of D1 dopamine receptors labelled with [3H]dopamine: distribution, regulation and relationship to coupling.
    Hervé D; Trovero F; Blanc G; Glowinski J; Tassin JP
    Neuroscience; 1992; 46(3):687-700. PubMed ID: 1532052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoradiographic localisation of D1 and D2 dopamine receptors in primordial striatal tissue grafts in rats.
    Mayer E; Heavens RP; Sirinathsinghji DJ
    Neurosci Lett; 1990 Feb; 109(3):271-6. PubMed ID: 2139499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. II. Effects of 6-hydroxydopamine or colchicine microinjections into the VTA or reserpine treatment.
    Joyce JN
    Exp Neurol; 1991 Sep; 113(3):277-90. PubMed ID: 1833220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S; Markstein R
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential ontogeny of functional dopamine and muscarinic receptors mediating presynaptic inhibition of neurotransmitter release and postsynaptic regulation of adenylate cyclase activity in rat striatum.
    De Vries TJ; Mulder AH; Schoffelmeer AN
    Brain Res Dev Brain Res; 1992 Mar; 66(1):91-6. PubMed ID: 1350950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrastriatal dopamine-rich implants reverse the changes in dopamine D2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: an autoradiographic study.
    Savasta M; Mennicken F; Chritin M; Abrous DN; Feuerstein C; Le Moal M; Herman JP
    Neuroscience; 1992; 46(3):729-38. PubMed ID: 1532053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Yates TM
    Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoradiographic study of striatal D1 and D2 dopamine receptors in 6-OHDA-lesioned rats receiving foetal ventral mesencephalic grafts and chronic treatment with L-dopa and carbidopa.
    Blunt SB; Jenner P; Marsden CD
    Brain Res; 1992 Jun; 582(2):299-311. PubMed ID: 1393551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional recovery of supersensitive dopamine receptors after intrastriatal grafts of fetal substantia nigra.
    Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK
    Exp Neurol; 1991 Mar; 111(3):282-92. PubMed ID: 1825638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic and dopaminergic receptor subtypes on striatal cholinergic interneurons.
    Dawson VL; Dawson TM; Wamsley JK
    Brain Res Bull; 1990 Dec; 25(6):903-12. PubMed ID: 2149667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide messenger RNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels.
    Cenci MA; Campbell K; Björklund A
    Neuroscience; 1993 Nov; 57(2):275-96. PubMed ID: 8115038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.